It’s a little known fact that most of the things that today look ordinary, before were only available for a limited group of people. For example, the World Wide Web, GPS system, duct tape, drones, microwaves ovens and many others, were originally set up for army needs. But at the end of the day, all of them found a wide use in daily lives.
On the other hand, there are some products and services, whose initial audience or market segment already focuses on ordinary people. But as peculiar as it may sound, the most needed and important among them are available only to the few people who are able to pay for them. It should be noted that this group is the one which includes, for the most part, medical products, drugs and therapies.
Money is crucial, even for health
By way of example, Martin Shkreli, also known as the “most hated man in America”, must be mentioned. Once his company, Turing Pharmaceuticals, has acquired the rights to the Daraprim drug, used to treat AIDS, malaria and cancer patients, its price spiked by 5,000%, from $13,50 to $700. Now, what we observe here is a typical monopoly situation: there is one company that has absolute market power, thereby it can set a monopoly price that will be above the firm’s economic cost.
According to the theory of supply and demand, with an increase in price, demand should decrease, however it wouldn’t be the right approach in our case. We should take into account that medical supplies form part of inelastic goods group. They have fewer substitutes, thus, their price change doesn’t affect the quantity demanded as much.
Another example of inelastic good is stem cells therapy. It’s helpful not only in keeping a face young but also in solving such health issues like blindness, nerve regeneration, liver restoration and other age-related diseases. If it is done thoughtfully, no doubt it is a panacea for reversing the ageing process.
Stem cells therapy consists in introducing fresh stem cells in our bodies, thus activating weakened cells and proliferating important cells declining in number daily. Once finding out damaged tissues, the stem cells are activated by themselves to try to repair and regenerate the tissues. It’s worth mentioning that different stem cells have been reported to be applicable in different areas.
Stem cells applications are very much in their infancy and there is a need to investigate further, nevertheless they might already boast implementation in over 250 forms of treatment and new discoveries.
Yet a strong interest in pursuing research on the ageing process continues to exist thanks to the involvement of all major parties in the medical-scientific community. It is no longer a question of whether or not ageing can be reversed. The question that we must raise is “Why hasn’t it gained popularity yet?”
The main issue with this therapy is the price. Due to a low number of clinics that offer such services, only rich and famous people including celebrities, actors, politicians, multi-billionaires and sport stars, can afford it. As has already been seen, what once was available only to wealthy high net-worth people has now been made available to almost everyone. Another problem is the lack of awareness of the nature of the anti-ageing effort and what must be done.
Stem cells therapy is starting to gain momentum
To solve these problems, a group of Japanese entrepreneurs, with the support of Association of Medical Corporation Koge-Kai, has decided to start a company named Stem Cell Project. The idea behind Stem Cell Project is to expand regenerative medicine to a worldwide level. It’s worth mentioning that up to date, this kind of therapy can be provided only in 5 countries such as the US, Germany, Switzerland, Russia (only at governmental institutions), and Japan.
In order to achieve these ambitious goals, Stem Cell Project has started working on developing the near-future health check system which can share automatic diagnoses with images and pathological data among clinics and hospitals in the world by using Artificial Intelligence and Blockchain technologies.
Also, they are developing a Virtual Clinic Platform, which can make patients feel a closer connection to doctors by using the network among the member hospitals/clinics of Japan Society of Aesthetic Regenerative Medicine. Thanks to a variety of such features as remote medical checkup system, a chatbot and translation function, Virtual Clinic will be a helpful tool in making online diagnosis and reducing patient wait times.
Most importantly, you will not have to spend the last of your money to take an advantage of this treatment and its technologies.
Recent technological developments made virtual clinics a reality. Thanks to the blockchain and AI, Stem Cell Project bridges the healthcare gap and provide services to populations that were previously underserved. However, the main merit of Stem Cell Project is making anti-ageing reversal process real, and affordable.
To become part of the project and help in diffusing the stem cells therapy you can join Stem Cell Project’s crowdsale! The Soft Cap for the sale is 2 million USD and the Hard Cap is 125 million USD.There are three stages, with a different discount in each of them, to purchase the SCC tokens:
- Pre-ICO: May 16 – September 15, 2018 (300,000,000 SCC have been already sold out. Now the SCC Token is offered at the price of 10 JPY per token).
- Private sale: September 16 – September 30, 2018 (400,000,000 SCC at the price of 12 JPY per token).
- Public Sale: October 16 – October 30, 2018 (200,000,000 SCC at the price of 14 JPY or 0.14 USD).
The SCC tokens can be purchased using BTC, ETH, NEO cryptocurrencies. Join now and enjoy the advantages of being an early-bird contributor!
Disclaimer The views, opinions, positions or strategies expressed by the authors and those providing comments are theirs alone, and do not necessarily reflect the views, opinions, positions or strategies of CoinGape. Do your market research before investing in cryptocurrencies. The author or publication does not hold any responsibility for your personal financial loss.
This author could be anybody, but he/she is not a member of staff coingape.com and opinions in the article are solely of the guest writer and do not reflect Coingape’s view.